Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

MeSH terms

• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / therapeutic use*
• Biological Products / adverse effects
• Biological Products / therapeutic use*
• Drug Monitoring / methods
• Drug Monitoring / standards*
• Gastrointestinal Agents / adverse effects
• Gastrointestinal Agents / therapeutic use*
• Humans
• Inflammatory Bowel Diseases / diagnosis
• Inflammatory Bowel Diseases / drug therapy*
• Inflammatory Bowel Diseases / immunology
• Predictive Value of Tests
• Standard of Care*
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*
• Tumor Necrosis Factor-alpha / immunology